Nuzenio

Ibogaine

Ibogaine news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 22:23:51 GMTPsyence BioMed’s Big Bet Is Vertical Psilocybin And Ibogaine Supply - Finimize
Thu, 06 Aug 2026 23:15:34 GMTArizona Is Paying $5 Million for an Ibogaine Trial in Brain Injury, Using a Drug That Is Illegal Federally and Can Stop the Heart - medicaldaily.com
Thu, 06 Aug 2026 22:51:18 GMTA look inside ibogaine drug treatment for veterans - Fox News
Thu, 06 Aug 2026 20:03:02 GMTPsyence BioMed (Nasdaq: PBM) outlines psilocybin and ibogaine clinical plans - Stock Titan
Thu, 06 Aug 2026 13:05:51 GMTUniversity awarded US$5 million for clinical trial of ibogaine in TBI - NR Times
Thu, 06 Aug 2026 04:31:00 GMTBarrow launches clinical study of ibogaine for neurological recovery - News-Medical

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ibogaine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.